Greenlight Biosciences Holdings Probability of Future Stock Price Finishing Over 0.30
| GRNADelisted Stock | USD 0.30 0.00 0.00% |
Greenlight |
Greenlight Biosciences Target Price Odds to finish over 0.30
The tendency of Greenlight Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.30 | 90 days | 0.30 | about 34.46 |
Based on a normal probability distribution, the odds of Greenlight Biosciences to move above the current price in 90 days from now is about 34.46 (This Greenlight Biosciences Holdings probability density function shows the probability of Greenlight Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.08 . This usually indicates Greenlight Biosciences Holdings market returns are sensitive to returns on the market. As the market goes up or down, Greenlight Biosciences is expected to follow. Additionally Greenlight Biosciences Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Greenlight Biosciences Price Density |
| Price |
Predictive Modules for Greenlight Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Greenlight Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Greenlight Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Greenlight Biosciences is not an exception. The market had few large corrections towards the Greenlight Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Greenlight Biosciences Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Greenlight Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.45 | |
β | Beta against Dow Jones | 1.08 | |
σ | Overall volatility | 0.05 | |
Ir | Information ratio | -0.06 |
Greenlight Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Greenlight Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Greenlight Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Greenlight Biosciences is not yet fully synchronised with the market data | |
| Greenlight Biosciences has some characteristics of a very speculative penny stock | |
| Greenlight Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.38 M. Net Loss for the year was (167.06 M) with loss before overhead, payroll, taxes, and interest of (87.22 M). | |
| Greenlight Biosciences Holdings currently holds about 44.13 M in cash with (136.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 43.0% of the company shares are held by company insiders |
Greenlight Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Greenlight Stock often depends not only on the future outlook of the current and potential Greenlight Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Greenlight Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 132 M | |
| Cash And Short Term Investments | 68.1 M |
Greenlight Biosciences Technical Analysis
Greenlight Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Greenlight Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Greenlight Biosciences Holdings. In general, you should focus on analyzing Greenlight Stock price patterns and their correlations with different microeconomic environments and drivers.
Greenlight Biosciences Predictive Forecast Models
Greenlight Biosciences' time-series forecasting models is one of many Greenlight Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Greenlight Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Greenlight Biosciences
Checking the ongoing alerts about Greenlight Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Greenlight Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Greenlight Biosciences is not yet fully synchronised with the market data | |
| Greenlight Biosciences has some characteristics of a very speculative penny stock | |
| Greenlight Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.38 M. Net Loss for the year was (167.06 M) with loss before overhead, payroll, taxes, and interest of (87.22 M). | |
| Greenlight Biosciences Holdings currently holds about 44.13 M in cash with (136.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 43.0% of the company shares are held by company insiders |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Greenlight Stock
If you are still planning to invest in Greenlight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Greenlight Biosciences' history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |